企業を読み込み中
Keep exploring
The themes Abbott Laboratories is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
Highest-graded in Medical Devices
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc$129.2BA+
SYKStryker Corp.$118.9BA+
EWEdwards Lifesciences Corporation$60.9BA+
GEHCGE Healthcare Technologies Inc.$37BA
GKOSGlaukos Corp$14.6BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A- EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
BIIBBiogen Inc.2026年10月28日BAGraded B, now A
どうやって稼いでいるか
- Medical devices50%
- Diagnostic products20%
- Nutrition products18%
- Established pharmaceutical products13%
売上構成比はquarter ended 2026-03-31の推計であり、提出された報告書の数字ではありません。
競合
何を売っているか6
Established Pharmaceutical Products
Branded generic medicines sold outside the United States, including treatments for digestive conditions, women's health, heart and metabolic conditions, pain, and respiratory infections.
Diagnostic systems and tests
Laboratory instruments, test kits, and rapid tests used to help detect or monitor conditions such as infections, cancer, heart problems, and thyroid disorders.
Nutrition products
Infant formula, adult nutrition drinks and powders, and products used for feeding patients in healthcare institutions, including Similac, Ensure, and PediaSure.
さらに3件を表示
Heart and other medical devices
Products include pacemakers, heart valves, devices used to treat narrowed blood vessels, and implanted devices for chronic pain or movement disorders.
FreeStyle Libre
A continuous glucose monitoring system with a sensor worn on the body to measure glucose levels for people with diabetes.
Cologuard
A stool-based test used to screen for colorectal cancer; Abbott discussed it on its earnings call as part of its cancer diagnostics business.
誰が買っているか6
- Hospitals, blood banks, and commercial laboratories buy diagnostic instruments, tests, and supplies directly or through distributors.
- Clinics, physicians' offices, and other care sites buy diagnostic tests and medical devices for use in patient care.
- Wholesalers, distributors, and pharmacies buy medicines for resale to healthcare providers and patients.
さらに3件を表示
- Retailers and consumers buy infant formula and adult nutrition products, including brands such as Similac and Ensure.
- Government agencies buy or influence access to medicines, diagnostic products, nutrition products, and medical devices.
- Healthcare institutions buy nutrition products used to feed patients.
何に支えられ、何に崩されうるか
事業が頼っているもの
- 1Making its products depends on a large network of suppliers around the world for raw materials and other supplies.
- 2Sales depend on government approvals and ongoing compliance rules for medicines, diagnostic tests, laboratories, nutrition products, and medical devices.
- 3Demand and prices can depend on government and insurer coverage, reimbursement rules, and cost-control programs, including competitive bidding for some infant formula contracts.
うまくいかなくなる可能性
- 1Disruptions to Abbott's global supply chain or problems in its or its suppliers' complex manufacturing processes could interrupt product availability.
- 2Changes to healthcare regulation, reimbursement, or price controls could delay product sales, restrict access, or reduce the prices Abbott receives.
- 3New products from competitors can reduce demand for Abbott's products, and some diagnostic and medical devices can become outdated quickly as technology changes.
Abbott Laboratoriesについて
Abbott develops, makes, and sells healthcare products around the world. Its businesses include branded generic medicines sold outside the United States, diagnostic tests and equipment, nutrition products, and devices for heart conditions, diabetes, and other needs. Its buyers include healthcare providers, distributors, retailers, government agencies, and consumers.
- 本社
- Abbott Park, Illinois, United States
- 設立
- 1888
- 従業員数
- approximately 115,000 (December 31, 2025, high)
- 上場市場
- New York Stock Exchange
- 決算期
- December 31
Abbott Laboratories 自身が米国証券取引委員会（SEC）に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。